In- VitroActivity of Commonly Used Antifungal Agents in the Presence of Rifampin, Polymyxin B and Norfloxacin againstCandida albicans
- 1 January 1995
- journal article
- Published by Taylor & Francis in Journal of Chemotherapy
- Vol. 7 (6) , 525-529
- https://doi.org/10.1179/joc.1995.7.6.525
Abstract
This study assessed the in-vitro antifungal activity against Candida albicans of amphotericin B, ketoconazole and miconazole, each in the presence of rifampin, polymyxin B and norfloxacin. Evaluation of drug interactions was estimated by the checkerboard pattern broth dilution method and by time-kill studies. Rifampin reduced the activity of the three antifungal agents used, with the reduction being more pronounced with amphotericin B. Synergy was observed when polymyxin B was combined with any of the antifungal agents used. The addition of norfloxacin resulted in minimal, if any, change in the activity.Keywords
This publication has 7 references indexed in Scilit:
- Significance of Drug Interactions With Rifampin in Pneumocystis carinii Pneumonia Prophylaxis-ReplyArchives of internal medicine (1960), 1992
- Pharmacokinetic study of the interaction between rifampicin and ketoconazoleJournal of Antimicrobial Chemotherapy, 1988
- Trichosporonosis in Patients with Neoplastic DiseaseMedicine, 1986
- Serum fungistatic and fungicidal activity in volunteers receiving antifungal agentsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1986
- Pulmonary Mycobacterium tuberculosis in acquired immune deficiency syndrome.BMJ, 1985
- Synergistic Action of Amphotericin Band Rifampin against Candida SpeciesThe Journal of Infectious Diseases, 1976
- Antifungal Properties of Polymyxin B and Its Potentiation of Tetracycline as an Antifungal AgentAntimicrobial Agents and Chemotherapy, 1972